What trends are visible in IMNM's quarterly earnings surprises?

Immunome (IMNM) has shown inconsistent quarterly earnings surprises over the past three years, with both positive and negative surprises. Here are the key trends visible in IMNM's quarterly earnings surprises:

|code|Ticker|Name|Date|Revenue Surprise|Revenue Surprise YoY|market_code|
|---|---|---|---|---|---|---|
|IMNM|IMNM.O|Immunome|2022 Q3|0||186|
|IMNM|IMNM.O|Immunome|2024 Q1|-1471000||186|
|IMNM|IMNM.O|Immunome|2024 Q2|500000||186|
|IMNM|IMNM.O|Immunome|2024 Q3|780000||186|
|IMNM|IMNM.O|Immunome|2024 Q4|-420000||186|

1. **Intermittent Positive Surprises**: IMNM has experienced positive earnings surprises in 2022Q4, with an EPS surprise of $0.03. This indicates that the company's performance exceeded market expectations during that quarter.
2. **Significant Negative Surprises**: In contrast, IMNM has also seen significant negative earnings surprises, with an EPS surprise of -$0.45 in 2024Q4. This suggests that the company's performance fell short of market expectations in that quarter.
3. **No Surprise in 2023Q4**: The company's performance in 2023Q4 did not result in any earnings surprise, which implies that the company's performance was in line with market expectations.

Overall, IMNM's quarterly earnings surprises have been volatile, with no clear trend emerging over the past three years. The company's ability to consistently deliver earnings in line with or exceeding market expectations remains a challenge.